![ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in Australia - ScienceDirect ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in Australia - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0031302518306159-gr1.jpg)
ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in Australia - ScienceDirect
![b. HER2 testing algorithm by dual probe in situ hybridisation Wolff AC... | Download Scientific Diagram b. HER2 testing algorithm by dual probe in situ hybridisation Wolff AC... | Download Scientific Diagram](https://www.researchgate.net/publication/277359615/figure/fig6/AS:350557240872962@1460590767164/b-HER2-testing-algorithm-by-dual-probe-in-situ-hybridisation-Wolff-AC-et-al-JCO-2013.png)
b. HER2 testing algorithm by dual probe in situ hybridisation Wolff AC... | Download Scientific Diagram
![Implementation of the 2018 American Society of Clinical Oncology/College of American Pathologists Guidelines on HER2/neu Assessment by FISH in breast cancers: predicted impact in a single institutional cohort | Modern Pathology Implementation of the 2018 American Society of Clinical Oncology/College of American Pathologists Guidelines on HER2/neu Assessment by FISH in breast cancers: predicted impact in a single institutional cohort | Modern Pathology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41379-019-0295-8/MediaObjects/41379_2019_295_Fig1_HTML.png)
Implementation of the 2018 American Society of Clinical Oncology/College of American Pathologists Guidelines on HER2/neu Assessment by FISH in breast cancers: predicted impact in a single institutional cohort | Modern Pathology
![Frontiers | Breast Cancer With a HER2 IHC2+ and FISH HER2/CEP17 Ratio ≥2.0 and an Average HER2 Gene Copy Number <4.0 per Tumor Cell: HER2 mRNA Overexpression Is a Rare Event Frontiers | Breast Cancer With a HER2 IHC2+ and FISH HER2/CEP17 Ratio ≥2.0 and an Average HER2 Gene Copy Number <4.0 per Tumor Cell: HER2 mRNA Overexpression Is a Rare Event](https://www.frontiersin.org/files/Articles/548621/fonc-10-00985-HTML/image_m/fonc-10-00985-g001.jpg)
Frontiers | Breast Cancer With a HER2 IHC2+ and FISH HER2/CEP17 Ratio ≥2.0 and an Average HER2 Gene Copy Number <4.0 per Tumor Cell: HER2 mRNA Overexpression Is a Rare Event
![Clinical significance of quantitative categorization of HER2 fluorescent in situ hybridization results in invasive breast cancer patients treated with HER2-targeted agents - Modern Pathology Clinical significance of quantitative categorization of HER2 fluorescent in situ hybridization results in invasive breast cancer patients treated with HER2-targeted agents - Modern Pathology](https://mp.uscap.org/cms/attachment/abea48ed-dd11-49cb-a605-81f83ae2e711/gr1_lrg.jpg)
Clinical significance of quantitative categorization of HER2 fluorescent in situ hybridization results in invasive breast cancer patients treated with HER2-targeted agents - Modern Pathology
![Interobserver Variation in the Assessment of Immunohistochemistry Expression Levels in HER2-Negative Breast Cancer: Can We Improve the Identification of Low Levels of HER2 Expression by Adjusting the Criteria? An International Interobserver Study - Interobserver Variation in the Assessment of Immunohistochemistry Expression Levels in HER2-Negative Breast Cancer: Can We Improve the Identification of Low Levels of HER2 Expression by Adjusting the Criteria? An International Interobserver Study -](https://mp.uscap.org/cms/attachment/c2aea33e-4069-491f-9f17-17c6c76ba532/gr1_lrg.jpg)
Interobserver Variation in the Assessment of Immunohistochemistry Expression Levels in HER2-Negative Breast Cancer: Can We Improve the Identification of Low Levels of HER2 Expression by Adjusting the Criteria? An International Interobserver Study -
![Figure 3 from Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. | Semantic Scholar Figure 3 from Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/22a3980f48cd672241df3eaefc79b28510b3576b/11-Figure3-1.png)
Figure 3 from Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. | Semantic Scholar
Effect of the 2013 ASCO-CAP HER2 Testing Guideline on the Management of IHC/ HER2 2+ Invasive Breast Cancer
![PDF] Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines | Semantic Scholar PDF] Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d99c6aa1dcc660fbabc1af5e20d607b8747a33a1/3-Figure1-1.png)
PDF] Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines | Semantic Scholar
![Quantitative assessments and clinical outcomes in HER2 equivocal 2018 ASCO/ CAP ISH group 4 breast cancer | npj Breast Cancer Quantitative assessments and clinical outcomes in HER2 equivocal 2018 ASCO/ CAP ISH group 4 breast cancer | npj Breast Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41523-019-0122-x/MediaObjects/41523_2019_122_Fig3_HTML.png)
Quantitative assessments and clinical outcomes in HER2 equivocal 2018 ASCO/ CAP ISH group 4 breast cancer | npj Breast Cancer
![Figure 2 from Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. | Semantic Scholar Figure 2 from Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/22a3980f48cd672241df3eaefc79b28510b3576b/10-Figure2-1.png)
Figure 2 from Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. | Semantic Scholar
![Figure. HER2 status of breast cancer cells determined by HER2 testing;... | Download Scientific Diagram Figure. HER2 status of breast cancer cells determined by HER2 testing;... | Download Scientific Diagram](https://www.researchgate.net/publication/321177070/figure/fig1/AS:562953582596096@1511230001048/Figure-HER2-status-of-breast-cancer-cells-determined-by-HER2-testing-The-ASCO-CAP-HER2.png)
Figure. HER2 status of breast cancer cells determined by HER2 testing;... | Download Scientific Diagram
![Frontiers | HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer Frontiers | HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer](https://www.frontiersin.org/files/Articles/834651/fmolb-09-834651-HTML/image_m/fmolb-09-834651-g002.jpg)
Frontiers | HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer
![a. HER2 testing algorithm by immunohistochemistry -Wolff AC et al. JCO... | Download Scientific Diagram a. HER2 testing algorithm by immunohistochemistry -Wolff AC et al. JCO... | Download Scientific Diagram](https://www.researchgate.net/publication/277359615/figure/fig1/AS:350557236678656@1460590766325/a-HER2-testing-algorithm-by-immunohistochemistry-Wolff-AC-et-al-JCO-2013.png)
a. HER2 testing algorithm by immunohistochemistry -Wolff AC et al. JCO... | Download Scientific Diagram
![PDF] THE BOTTOM LINE Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer : American Society of Clinical Oncology / College of American Pathologists Clinical Practice Guideline Focused Update Guideline Questions | Semantic Scholar PDF] THE BOTTOM LINE Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer : American Society of Clinical Oncology / College of American Pathologists Clinical Practice Guideline Focused Update Guideline Questions | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/747f72db6685fa520b07391fb016bac6754d7633/9-Figure3-1.png)
PDF] THE BOTTOM LINE Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer : American Society of Clinical Oncology / College of American Pathologists Clinical Practice Guideline Focused Update Guideline Questions | Semantic Scholar
![Impact of the 2018 ASCO/CAP guidelines on HER2 fluorescence in situ hybridization interpretation in invasive breast cancers with immunohistochemically equivocal results | Scientific Reports Impact of the 2018 ASCO/CAP guidelines on HER2 fluorescence in situ hybridization interpretation in invasive breast cancers with immunohistochemically equivocal results | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-53003-w/MediaObjects/41598_2019_53003_Fig1_HTML.png)